Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve

N Engl J Med. 2021 Mar 11;384(10):975. doi: 10.1056/NEJMc2035891.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Atrial Fibrillation* / drug therapy
  • Humans
  • Mitral Valve / diagnostic imaging
  • Mitral Valve / surgery
  • Rivaroxaban* / therapeutic use
  • Warfarin

Substances

  • Anticoagulants
  • Warfarin
  • Rivaroxaban